A specific protein implicated in the cognitive decline of Alzheimer’s disease also appears to play a role in genetic predisposition to schizophrenia, meaning that a drug that targets that protein could treat a variety of neuropsychiatric disorders, according to a new study published October 18 in the journal Molecular Psychiatry.
from Dementia Big http://ift.tt/2erKFny via alcoholic dementia
http://ift.tt/2dPNb72
No comments:
Post a Comment